Search

Your search keyword '"Durable polymer"' showing total 343 results

Search Constraints

Start Over You searched for: Descriptor "Durable polymer" Remove constraint Descriptor: "Durable polymer"
343 results on '"Durable polymer"'

Search Results

101. P3393Comparison of intermediate-term vascular response to new-generation biodegradable polymer and durable polymer-based drug-eluting stents: optical coherence tomographic study

102. P2796Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients: a 3-year propensity-matched study

103. P2799Long-term outcomes after percutaneous coronary intervention with biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent: evidence from a meta-analysis

104. P6241Two-year clinical outcomes of biodegradable polymer versus durable polymer drug-eluting stent implantation in hemodialysis patients after percutaneous coronary intervention

105. Timely and Durable Polymer Modified Patching Materials for Pothole Repairs in Low Temperature and Wet Conditions

106. Clinical outcomes of new-generation drug-eluting stents in patients with coronary artery disease: meta-analyses of randomised controlled trials

107. Comparison of the biodegradable polymer everolimus-eluting stent with contemporary drug-eluting stents: A systematic review and meta-analysis

108. Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents

109. A Randomized Comparison of the Healing Response Between the Firehawk Stent and the Xience Stent in Patients With ST-Segment Elevation Myocardial Infarction at 6 Months of Follow-Up (TARGET STEMI OCT China Trial): An Optical Coherence Tomography Study.

110. Real-World Long-Term Clinical Outcomes of Ultrathin Strut Biodegradable Polymer Drug-Eluting Stents in Korean ST-Segment-Elevation Myocardial Infarction (STEMI) Patients with or without Acute Heart Failure Undergoing Primary Percutaneous Coronary Intervention

111. Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)

112. Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial

114. BIODEGRADABLE POLYMER SIROLIMUS ELUTING STENT (ORSIRO) VERSUS SECOND GENERATION DURABLE POLYMER DRUG ELUTING STENTS: A META-ANALYSIS OF RANDOMISED TRIALS

115. COMPARISON OF LONG-TERM OUTCOMES WITH BIODEGRADABLE POLYMER DRUG ELUTING STENTS AND DURABLE POLYMER DRUG ELUTING STENTS: AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

116. CRT-100.35 Comparison of Biodegradable-Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent—a Meta-Analysis of Randomized Trials

117. High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial

118. Short-term stent coverage of second-generation zotarolimus-eluting durable polymer stents: Onyx one-month optical coherence tomography study

119. Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy

120. Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis

121. Biodegradable-polymer stents versus durable-polymer stents

122. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization

124. P2630Comparison of tissue characteristics in restenosis lesion between bioabsorbable polymer drug-eluting stent and durable polymer drug-eluting stent

125. P2774Comparison of coronary angioscopic findings after stent implantation among 2 kinds of novel biodegradable polymer-coated and one durable polymer-coated drug-eluting stent

126. P791Comparison between a novel bioabsorbable polymer everolimus-eluting stent and a durable polymer everolimus-eluting stent

127. P2638Comparison of in-stent responses in 8 month between durable polymer and bioabsorbable polymer everolimus-eluting stent: serial observation with angioscopy and optical coherence tomography

128. P5525A meta-analysis of randomised controlled trials to compare safety and efficacy of everolimus/sirolimus bioabsorbable polymer with second-generation durable-polymer drug eluting stents

129. Biodegradable polymer versus second-generation durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis

130. Long-Term Investigation on the Compressive Strength of Polymer Concrete with Fly Ash

131. TCTAP A-134 Biodegradable Polymer vs. Durable Polymer Drug-eluting Stents in Patients with Acute Myocardial Infarction Patients

132. Comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study.

133. Improving vessel healing with fully bioresorbable drug-eluting stents: more than a pipe dream?

134. Coronary Stent Materials and Coatings: A Technology and Performance Update

135. Stent Thrombosis with Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents: An Update Meta-Analysis

136. Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction

137. Mechanochemistry of Polymer Brushes

138. Real life experience with bioresorbable-polymer everolimus-eluting stents. Is this an answer in search of a question?

139. P3316Long-term clinical outcomes of the bifurcation intervention: 3-year clinical follow-up for biodegradable-polymer biolimus A9-eluting stents vs. durable-polymer everolimus or zotarolimus-eluting stents

140. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging

141. Two-year vascular responses to drug-eluting stents with biodegradable polymer versus durable polymer: An optical coherence tomography sub-study of the NEXT

142. Clinical outcomes of bioresorbable versus durable polymercoated everolimus-eluting stents in real-world complex patients

143. A Randomized Comparison of Novel Biodegradable Polymer- and Durable Polymer–Coated Cobalt-Chromium Sirolimus-Eluting Stents

144. Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: Five-year follow-up optical coherence tomography study

145. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model

146. Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

147. Vascular Response to Drug-Eluting Stent With Biodegradable vs. Durable Polymer

148. TCT-665 Unselected use of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for coronary revascularization

150. TCT-305 Real-World Experience of Biodegradable-Polymer Drug Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Catalog

Books, media, physical & digital resources